Intravitreal triamcinolone and elevated intraocular pressure.
To ascertain whether intravitreal triamcinolone given for subretinal neovascularization is associated with an ocular pressure rise. A total of 113 patients with angiographically proven subretinal neovascularization were enrolled into a prospective study of the effects of intravitrea triamcinolone. Intraocular pressure was one of the parameters studied. Approximately 30% of the study group developed a significant rise (> or =5 mm Hg) in intraocular pressure above baseline during the first 3 months. Patients considering this form of treatment should be fully informed of the known risks of intraocular injections of steroids.